HeartSciences (HSCS) Stock Price, News & Analysis

Company Overview

HeartSciences, Inc. (NASDAQ: HSCS) is a medical technology company focused on improving the detection and diagnosis of heart disease. The company develops electrocardiography (ECG) technologies designed to provide clinicians with additional information about cardiac function using a familiar, noninvasive test.

Its principal product is the MyoVista waveform ECG, which uses proprietary time-frequency analysis to evaluate electrical signals from the heart. The technology is intended to help identify abnormalities that may be associated with impaired cardiac relaxation, including diastolic dysfunction, which can be difficult to detect with conventional ECG methods.

HeartSciences markets its products to healthcare providers and cardiovascular-care organizations. The company’s technology has received regulatory clearance for use in the United States and has also been made available in international markets, including Europe. HeartSciences is headquartered in Southlake, Texas.

Key Stats

• Today's Range: $3.15 to $3.44
• 50-Day Range: $2.00 to $5.20
• 52-Week Range: $1.63 to $5.25
• Volume: 109,299 shs
• Average Volume: 270,791 shs
• Market Capitalization: $15.40 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $8.00
• Consensus Rating: Hold

HeartSciences Stock Analysis - MarketRank™

HeartSciences scored higher than 66% of companies evaluated by MarketBeat, and ranked 270th out of 883 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

HeartSciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

HeartSciences has a consensus price target of $8.00, representing about 151.6% upside from its current price of $3.18.

Amount of Analyst Coverage

HeartSciences has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for HeartSciences are expected to grow in the coming year, from ($2.99) to ($2.01) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of HeartSciences is -0.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of HeartSciences is -0.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

HeartSciences has a P/B Ratio of 45.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.61% of the float of HeartSciences has been sold short.

Short Interest Ratio / Days to Cover

HeartSciences has a short interest ratio ("days to cover") of 0.17, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in HeartSciences has recently decreased by 29.93%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

HeartSciences does not currently pay a dividend.

Dividend Growth

HeartSciences does not have a long track record of dividend growth.

News and Social Media

• Score: 4.3 / 5
• News Sentiment: 0.83

News Sentiment

HeartSciences has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for HeartSciences this week, compared to 2 articles on an average week.

Search Interest

2 people have searched for HSCS on MarketBeat in the last 30 days.

MarketBeat Follows

2 people have added HeartSciences to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, HeartSciences insiders have not sold or bought any company stock.

Percentage Held by Insiders

4.90% of the stock of HeartSciences is held by insiders.

Percentage Held by Institutions

17.24% of the stock of HeartSciences is held by institutions.

Company Calendar

• Last Earnings: 9/14/2026
• Today: 10/10/2026
• Next Earnings (Estimated): 12/21/2026
• Fiscal Year End: 4/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:HSCS
• CIK: 1468492
• Web: heartsciences.com
• Phone: 682-237-7781
• Fax: N/A
• Employees: 14
• Year Founded: N/A

Price Target and Rating

• Average Price Target for HeartSciences: $8.00
• High Price Target: $8.00
• Low Price Target: $8.00
• Potential Upside/Downside: +151.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($3.22)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$9.14 million
• Net Margins: N/A
• Pretax Margin: -256,474.97%
• Return on Equity: -816.90%
• Return on Assets: -181.97%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.14
• Quick Ratio: 0.07

Sales & Book Value

• Annual Sales: $4.52 thousand
• Price / Sales: 3,408.70
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.07 per share
• Price / Book: 45.43

Miscellaneous

• Outstanding Shares: 4,844,000
• Free Float: 4,607,000
• Market Cap: $15.40 million
• Optionable: Not Optionable
• Beta: 1.76